Substituted C-phenyl Glycitol compound

PK139942AUndetermined Publication Date: 2009-01-22TAISHO PHARMACEUTICAL CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
PK200700562
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-22

Smart Images

  • Figure PK139942A_A0001
    Figure PK139942A_A0001
  • Figure PK139942A_B0001
    Figure PK139942A_B0001
Patent Text Reader

Abstract

Provided is a novel C-phenyl glycitol compound that may serve as a prophylactic or therapeutic agent for diabetes by inhibiting both SGLT1 activity and SGLT2 activity, thereby exhibiting a glucose absorption suppression action and a urine glucose excretion action. A C-phenyl glycitol compound represented by Formula (I) below or a pharmaceutically acceptable salt thereof Wherein R1 and R2 are the same or different and represent a hydrogen atom, a hydroxyl group, a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom R 3 is a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom. Y is a C1-6 alkylene group, 0-(CH2) n- (n is an integer of 1 to 4)or a C2-6 alkenyulene group, provided that when Z is –NHC (=NH) NH2 or – NHCON (RB ) RC , n is not 1, Z is –CONHRA , -NHC(=NH) NH2 or –NHCON (RB ) RC
Need to check novelty before this filing date? Find Prior Art